Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – A coronary stent incorporating a polytetrafluoroethylene membrane does not live up to expectations in the treatment of diseased aortocoronary saphenous vein grafts, investigators…
NEW YORK (Reuters Health) – The combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) is often prescribed for elderly patients who do not…
NEW YORK (Reuters Health) – Compared with fibrinolytic therapy, primary percutaneous coronary intervention (PCI) in patients with acute MI is associated with a significant reduction in early mortality,…
NEW YORK (Reuters Health) – For patients with high platelet reactivity after percutaneous coronary intervention, treatment with a high-dose clopidogrel regimen does not improve outcomes compared with standard…
NEW YORK (Reuters Health) — Patients with chronic kidney disease (CKD) who are administered sodium bicarbonate before emergency coronary procedures might be less likely to suffer contrast-induced nephropathy…
NEW YORK (Reuters Health) – Encouraging results with total arch replacement combined with stented “elephant trunk” implantation suggest that this strategy should become a new standard of management…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses salivary cortisol testing which is increasingly being used in the diagnosis and treatment of patients with hypothalamic pituitary…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses stressand cardiovascular disease. Cortisol has effects in causing disease over the long-term. It lowers growth hormone levels, increases…
NEW YORK (Reuters Health) – Even with routine use of stents and thienopyridines such as clopidogrel for elective percutaneous coronary intervention, glycoprotein IIb/IIIa inhibitors (GPIs) such as abciximab…
NEW YORK (Reuters Health) – Clopidogrel improves outcomes not only in patients with myocardial infarction undergoing primary percutaneous coronary intervention, but also in MI patients revascularized by coronary…
